Ricerca
50 risultati per «intravenous corticosteroids»
Utilizzo delle immunoglobuline endovenose nella pratica clinica in pediatria
G. Ventura, M. Rabusin, E. Spinelli, R. Badolato — pp. 371-381
… 2004;163:229-33. 5. Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006;149:336-41. 6. Moreno N, Méndez-Echevarrìa A, de Inonencio J, et al. …
I corticosteroidi nelle malattie respiratorie: certezze e dubbi 60 anni dopo (Seconda parte)
F.M. de Benedictis, F. Franceschini, R. Budassi, A. Capolongo, C. Gobbi, A. Guerrieri, C. Migliori, A. Nobilini, C. Pasqualini — pp. 652-659
… Vengono di seguito discusse le principali malattie in cui può essere prevista l’utilizzazione dei CS. 652 CORTICOSTEROIDS IN RESPIRATORY DISEASES: CERTAINTIES AND DOUBTS 60 YEARS LATER (Second part) (Medico e Bambino 2012;31:652-659) Key words Corticosteroids, Respiratory diseases, Children, …
I corticosteroidi nelle malattie respiratorie: certezze e dubbi 60 anni dopo (Prima parte)
F.M. de Benedictis, A. Andreozzi, R. Budassi, A. Capolongo, C. Gobbi, A. Guerrieri, C. Migliori, A. Nobilini, C. Pasqualini — pp. 585-588
… genica aumentando o riducendo la trascrizione di geni (effetto genomico Medico e Bambino 9/2012 CORTICOSTEROIDS IN RESPIRATORY DISEASES: CERTAINTIES AND DOUBTS 60 YEARS LATER (First part) (Medico e Bambino 2012;31:585-588) Key words Corticosteroids, Anti-inflammatory drugs, Meccanism …
La gestione del bambino con malattia di Kawasaki: un approccio basato sull’evidenza
G. Orso, R. Vitiello, G. Nocerino, L. De Seta — pp. 222-229
… on coronary artery involvement. Pediatrics 1979 Feb;63(2):175-9. 37. Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 1999 Oct; 135(4):465-9. 38. Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki …
Salbutamolo e cortisonici nell’accesso acuto d’asma
E. Barbi, et al. — pp. 559-565
… childhood with acute asthma. J Pediatr 1993; 123:313-7. 22. Smith M, Iqbal S, Elliot TM, Everard M, Rowe BH. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003(2):CD002886. 23. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency …
La gestione dell’accesso asmatico acuto in Pronto Soccorso (e non solo)
G. Longo, M. Maschio, E. Panontin, F. Marchetti, G. Furcolo, F. Quarantiello — pp. 563-569
… Key words Emergency asthma management, Guidelines, Asthma severity, Inhaled β2-agonist, Oral corticosteroids, Salbutamol Summary The management of acute asthma, as a medical emergency, must be organized in advance by providing materials and tools for an immediate and easy use, …
Corea reumatica: tre “C” che dicono tutto
F. Baldo, A. Taddio, A. Ventura — pp. 295-300
… EVERYTHING ABOUT RHEUMATIC CHOREA (Medico e Bambino 2018;37:295-300) Key words Sydenham's Chorea, Carditis, Corticosteroids, Rheumatic Fever Summary Although Sydenham’s chorea is an uncommon manifestation of rheumatic fever, it is still the most frequent cause of chorea in children. It is …
Kawasaki facile e difficile
E. Benelli, S. Carbogno, N.S. Carucci, M. Gori, E. Marrani, M. Melis, M.C. Pellegrin — pp. 155-162
… Key words Kawasaki disease, Retropharyngeal abscess, Febrile cholestatic jaundice, Hemophagocytic syndrome, Corticosteroids, Acetylsalicylic acid Summary Kawasaki disease (KD) is a systemic vasculitis that typically affects children of 2-5 years of age and whose diagnosis and treatment are …
Malattia di Kawasaki: quale dose di immunoglobuline nei bambini grandi?
L. Mambelli, A. Iacono, G. Rametta, F. Marchetti — pp. 231-233
… malattia di Kawasaki? Medico e Bambino pagine elettroniche 2014;17(3). Ae R, Abrams JY, Maddox RA, et al. Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high-risk patients with Kawasaki disease. J Am Heart Assoc …
La porpora di Schönlein-Henoch
L. Calligaris, L. Calligaris, F. Marchetti, E. Barbi, E. da Dalt, E. Panontin, L. Lepore, A. Ventura — pp. 19-26
… PURPURA (HSP) (Medico e Bambino 2009;28:19-26) Key words Henoch-Schönlein purpura, Nephritis, Corticosteroids, Overview Summary Henoch-Schönlein purpura (HSP) is the most common vasculitic disease of childhood. HSP is a multisystem immunoglobulin A-mediated vasculitis with a …
La fine della questione sull’uso del cortisone nella malattia di Kawasaki?
F. Marchetti
… JW, Baker A, Sundel RP. Treatment of immunoglobulin resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9. Bartolozzi G. Il trattamento, fin dall’inizio, della malattia di Kawasaki con corticosteroidi. Medico e Bambino pagine elettroniche 2005;8(10). …
Terapia farmacologica in urgenza
Squillaci D, Tumminelli C, Molina Ruiz I, Calligaris L, Poropat F, Barbi E, Amaddeo A, Cozzi G. — pp. 441-450
… 2018;34 (6):3905. doi: 10.1097/PEC.0000000000000 909. 9. Smith M, Iqbal S, Elliott TM, Everard M, Rowe BH. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003;2003(2):CD002886. doi: 10.1002/14651858.CD002886. 10. Longo G. Il cortisone nel viral wheezing …
Novità in Pediatria pratica 1997-98
F. Panizon — pp. 661-691
… I glucocorticoidi per via inalatoria. Medico e Bambino 6, 367-73, 1998. 17. Allen DB: Influence of inhaled corticosteroids on growth: a pediatric endocrinologist’s perspective. Acta Paediatr 87, 123, 1998. 18. Doull IJM, Campbell MJ, Holgate T: Duration of growth suppressive effects of regular …
Il trattamento farmacologico della bronchiolite
E. Barbi, G. Cavagni — pp. 247-251
… 1998;26:162-6. 3. Cade A, Brownlee K, Conway S, et al. Randomized placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82:126-30. 4. Cochrane Database Syst Rev. Bronchodilators for bronchiolitis 2000;(2):CD001266. 5. …
Infezioni delle vie urinarie: dalla diagnosi alla terapia
De Pra S, Benvenuto S, Pennesi M. — pp. 557-560
… shown that the effectiveness of a 5-day antibiotic therapy is not inferior to a 10-day one. The addition of corticosteroids, although it is safe, does not show solid evidence regarding its benefit and remains at the clinician's discretion. After a first episode of UTI, a renal ultrasound should …
Dermatomiosite giovanile: caso clinico complesso | MeB
Morreale DM, Carlino C, Taverniti M, Maggio MC, Alizzi C, Allegra M, Corsello G — pp. 111-112
… was diagnosed with juvenile dermatomyositis and treated initially with intravenous immunoglobulin (IVIg) and corticosteroids, followed by hydroxychloroquine (useful especially in resistant cutaneous and articular manifestations) and methotrexate due to insufficient response. Her condition …
Kawasaki disease shock syndrome: una rara modalità di presentazione della malattia
N. Sardi, C. Galletto, L. Besenzon
… presenting with atypical KD, complicated by severe shock syndrome and successfully treated with steroids and intravenous immunoglobulins (IVIg). Riassunto La Kawasaki disease shock syndrome (KDSS) è una rara e severa presentazione della malattia di Kawasaki (MK), spesso difficile da diagnosticare, …
Sindrome di Kawasaki: l’uso dei corticosteroidi alla luce delle evidenze
V. Murgia — pp. 187-188
Sindrome DRESS: da un caso clinico particolare alla rivisitazione della patologia
Manieri S, De Gregorio F, Mirauda MP, Colangelo C, Tagliente M, Abate R, Romaniello L, Lapolla R, Salvatore D — pp. 10-16
… treatment of choice is the prompt withdrawn of the offending drug and using intravenous immunoglobulins and corticosteroids used in synergy. In recent years, emerging studies have outlined the disease more clearly. We present a paediatric case in which the patient developed DRESS syndrome as a …
Ha ancora un ruolo l’uso dell’aspirina nella malattia di Kawasaki e, se sì, a quale dosaggio?
F. Marchetti, L. Mambelli, S. Pusceddu
… 2004;110(17):2747�71. Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006;149:336�41. Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for …
NOVITA' IN PEDIATRIA PRATICA 2007-2008
F. Panizon — pp. 639-670
… observational surveillance study. Lancet 2008;371:1108-13. 4. Scarborough M, Gordon SB, Whitty CJ, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007;357:2441-50. 5. Nguyen TH, Tran TH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents …
La sindrome di Kawasaki e la sua terapia Morire… per non sentire dolore Caso indimenticabile e... la fine del mondo attraverso i farmaci (biologici) Bambini che si fanno del male: pensa al bullismo Sudori notturni Pediatria sul NEJM: ancora un caso indimenticabile
pp. 283-284
Ha ancora un ruolo l’uso dell’aspirina nella malattia di Kawasaki e, se sì, a quale dosaggio?
F. Marchetti, L. Mambelli, S. Pusceddu — pp. 667-668
… 2004;110: 2747-71. 6. Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006; 149:336-41. 7. Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for …
Mani-piedi-bocca… cervello! Una complicanza inattesa
Zuccoli C, Cazzaniga F, Sangiorgio A, De Santis L, Cogliardi A. — pp. 457
… and MRI findings were consistent with inflammatory central nervous system involvement. Treatment with intravenous immunoglobulins led to full neurological recovery. Although HFMD is typically benign, rare severe neurological complications may occur, therefore its early recognition and …
Effetto dell’esposizione al traffico autostradale sullo sviluppo del polmoneUtilità dei corticosteroidi nel trattamento inizialedella malattia di Kawasaki
pp. 387-388
… clinico, pubblicato su Journal of Pediatrics (Inoue Y, et al. A multicentric prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical corse and coronary artery outcome. J Pediatr 2006;149:336-41), in cui il trattamento sperimentale con prednisone 2 …
Vasculiti facili e difficili: cosa deve sapere e saper fare un pediatra
De Nardi L, Petrone MI, Benvenuto S, Natoli V, Abu-Rumeileh S, Castaldo B, De Benedetti F. — pp. 286-298
… JAMA Pediatr 2016;170(12):1156. doi: 10.1001/jamapediatrics.2016.2055. 24. Green J, Wardle AJ, Tulloh RM. Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2022;5(5):CD011188. doi: 10.1002/14651858. CD011188.pub3. 25. Okubo Y, Michihata N, Morisaki N, …
La Pediatria sulla Grande Stampa 2010
pp. 1
… R Jr, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010;362:975-85). Va detto tuttavia che singoli bambini sono sembrati giovarsi di più del montelukast o dell’aumento di dose del corticosteroide, cosa che, a …
Le priorità associate all’uso dei farmaci “off-label”
F. Marchetti, J. Bua, S. Demarini, et al. — pp. 527-531
… units. Our findings showed that the most common reasons detected for off-label use were formulation and age. Corticosteroids, antihypertensive drugs and midazolam were most frequently indicated as off-label for formulation, while ciprofloxacin, new generation anti-epilepsy drugs (lamotrigine, …
Gestione del Covid-19 in età pediatrica: documento di consenso
Gruppo di Lavoro su Covid-19 in Pediatria della Regione Emilia-Romagna (RE-CO-PED) — pp. 85-101
… (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With Covid-19: A Meta-analysis. JAMA 2020;324:1330-41. 116. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, et al. …
Crisi celiaca: una complicanza rara e insidiosa della celiachia
Barca M, Boccia M, Improta M, Discepolo V — pp. 59-63
… Santander C. Non-responsive coeliac disease: Coeliac crisis vs. refrac-tory coeliac disease with response to corticosteroids. Gastroenterol Hepatol. 2017;40(8):529-30. English, Spanish. DOI: 10.1016/j.gastrohep. 2016.07.003. Lloyd-Still JD, Grand RJ, Khaw KT, Shwachman H. The use of …
La sinusite nel bambino: come riconoscerla e quando preoccuparsi
Caiffa G, Grasso DL, Orzan E, Barbi E, Giuntoli DG. — pp. 433-439
… cases. Treatment is generally indicated only for moderate to severe forms and usually consists of topical corticosteroids and/or antibiotics. Complications occur in approximately 1 out of 12,000 cases of acute rhinosinusitis. Orbital complications are the most common, followed by intracranial …
Kawasaki, neutropenia febbrile e novità in pediatria
pp. 281-282
… studi randomizzati e di metanalisi, inclusa una Cochrane, che forniscono evidenze robuste (Green J, et al. Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2022;5(5): CD011188. doi: 10.1002/ 14651858.CD011188.pub3). I glucocorticoidi riducono la …
Le molte facce della malattia infiammatoria cronica intestinale
A. Ventura e coll. — pp. 509-527
… DAF, Chamers AH, Rigby HS: Unusual pulmonary complication of ulcerative colitis with a rapid response to corticosteroids: case report. Gut 35, 847, 1994. 40. Faure C, Belarbi N, Mougenot JF, et al: Ultrasonographic assessment of inflammatory bowel disease in children: comparison with …
Pronto Soccorso
Calligaris L, Poropat F, Cozzi G — pp. 14
… doi: 10.3109/23744235.2015.1078907. • Esposito S, Semino M, Picciolli I, Principi N. Should corticosteroids be used in bacterial meningitis in children? Eur J Paediatr Neurol 2013;17(1):24-8. doi: 10.1016/j.ejpn.2012.06.008. ONDANSETRON NELLA GASTROENTERITE La gastroenterite è …
Il trattamento, fin dall'inizio, della malattia di Kawasaki con corticosteroidi
G. Bartolozzi
Encefalite associata ad anticorpi anti-MOG: due casi a presentazione atipica
Di Jorgi M, Nebiolo M, Canzoneri F, Strati MF, Mancardi MM, Rossi A, Tardini G, Brisca G, Moscatelli A. — pp. 458
The paper presents two cases of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and highlights its significant clinical heterogeneity in the paediatric population. Early recognition of neurological red flags is crucial. The av...
La sindrome nefrosica in età pediatrica
Consensus della Società Italiana di Nefrologia Pediatrica (SINePe) — pp. 577-588
… 63. Dorlo TP, Jager NG, Beijnen JH, Schellens JH. Concomitant use of proton pump inhibitors and systemic corticosteroids. Ned Tijdschr Geneeskd 2013;157(19):A5540. 64. Munson JC, Wahl PM, Daniel G, Kimmel SE, Hennessy S. Factors associated with the initiation of proton pump inhibitors in …
La Pediatria sulla Grande Stampa 2019
Alessandro Ventura — pp. 1-66
… Una metanalisi appena pubblicata sugli Archives of Disease in Childhood (Cowley BJ, Dong J. Use of oral corticosteroids in the treatment of alopecia areata. 2020;105:96-98) prende in considerazione l’efficacia e gli effetti collaterali della terapia con corticosteroidi orali e conclude che, …
Corea di Sydenham: descrizione di cinque casi
E. Palumbo, M. Branchi, A. Siani, C. Malorgio, G. Nasca, G. Bonora
… Neurol 2000;23(2):147-51.Cardoso F, Maia D, Cunningham MC, Valenca G. Treatment of Sydenham chorea with corticosteroids. Mov Disord 2003;18(11):1374-7.Teixeira AL, Maia DP, Cardoso F. Treatment of acute Sydenham's corea with methyl-prednisolone pulse-therapy. Parkinsonism Relat Disord 2005; …
Bifosfonati e osteonecrosi della mandibola
G. Tornese
… M, Capocaccia P, Frediani T, Ferri F, Cucchiara S. Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate. J Pediatr Gastroenterol Nutr 2006;43(4):533-5. Baroncelli GI, Bertelloni S, Sodini F, Saggese G. …
"È intelligente ma non si applica": quando è solo una questione di anticorpi
Carnazzo SM, Balconara D, Caruso F, Ruggieri M, Falsaperla R — pp. 194-197
A diagnosis of steroid responsive encephalitis associated to autoimmune thyroiditis (Hashimoto encephalitis) was eventually made in a child with complex tics and decline of school performance....
Le bolle che non ti aspetti: un raro caso di pemfigo volgare in età pediatrica
Benelli E, Demarin GC, Corneli P, Gatti A, Martelossi S — pp. 21-24
… by intraepidermal blisters with a flaccid roof. Treatment should be prompt and appropriate, using full dose corticosteroids. It is also recommended the concomitant initiation of immunosuppressant therapies to allow the steroid to be phased out. There are rare secondary forms, which must therefore …
Gestione del bambino con bronchiolite: un approccio basato sull’evidenza
M. Macchiaiolo, E. Cascioli, L. Viola, PP. Mastroiacovo — pp. 291-298
… used in treating bronchiolitis? Pediatrics 46, 640-2, 1970. 17. Springer C, Bar-Yishay E, Uwayyed K, et al: Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonology 9,181-185, 1990. 18. De Boeck K: Respiratory synctitial virus …
La varicella
P. Petaros, F. Marchetti — pp. 89-98
… Dis J 1994;13(8): 748-50. 35. Choong K, Zwaigenbaum L, Onyett H.Severe varicella after low dose inhaled corticosteroids. Pediatr Infect Dis J 1995;14(9):809-11. 36. Nocerino G. Varicella emorragica con polmonite in corso di terapia con steroidi inalanti. Medico e Bambino 2003; n. 7; pagine …
La Pediatria sulla Grande Stampa 2018
Alessandro Ventura — pp. 1811-1811
… prolungamento non indifferente del tempo di vita in autonomia. Una revisione sistematica (Matthews E, et al. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev 2016;(5):CD003725) concludeva nel 2016 per un effetto positivo della terapia steroidea su forza …
Disordini demielinizzanti nel bambino e nell’adolescente: ADEM, neurite ottica e MOGAD
Dal Bo S, Ruscelli M, Cenni P, Piscaglia MG, D’Eliseo D, Marchetti F. — pp. 231-236
… and AQP4-seronegative NMOSD. The first-line of treatment commonly recognized in the acute phase is IV corticosteroids in high-dose or IV immunoglobulins. In case of relapse, the drug with evidence of efficacy is rituximab; other choices are immunosuppressive therapies, in particular …